Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.
Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.
复制标题
DOI:
10.1161/circresaha.110.218867
复制
发表时间:
2010-09-03
影响因子:
20.1
通讯作者:
Liew FY
中科院分区:
文献类型:
--
作者:
Miller AM;Asquith DL;Hueber AJ;Anderson LA;Holmes WM;McKenzie AN;Xu D;Sattar N;McInnes IB;Liew FY
Chronic low-grade inflammation involving adipose tissue likely contributes to the metabolic consequences of obesity. The cytokine IL-33 and its receptor ST2 are expressed in adipose tissue but their role in adipose tissue inflammation during obesity is unclear. To examine the functional role of IL-33 in adipose tissues, and investigate the effects on adipose tissue inflammation and obesity in vivo. We demonstrate that treatment of adipose tissue cultures in vitro with IL-33 induced production of Th2 cytokines (IL-5, IL-13, IL-10), and reduced expression of adipogenic and metabolic genes. Administration of recombinant IL-33 to genetically obese diabetic (ob/ob) mice led to reduced adiposity, reduced fasting glucose and improved glucose and insulin tolerance. IL-33 also induced accumulation of Th2 cells in adipose tissue and polarization of adipose tissue macrophages towards an M2 alternatively activated phenotype (CD206+), a lineage associated with protection against obesity-related metabolic events. Furthermore, mice lacking endogenous ST2 fed HFD had increased body weight and fat mass, impaired insulin secretion and glucose regulation compared to WT controls fed HFD. In conclusion, IL-33 may play a protective role in the development of adipose tissue inflammation during obesity.